Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
+$588M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Illumina
ILMN
|
+$398M |
| 4 |
argenx
ARGX
|
+$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$600M |
| 2 |
AbbVie
ABBV
|
+$323M |
| 3 |
Sherwin-Williams
SHW
|
+$309M |
| 4 |
Atlassian
TEAM
|
+$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
701
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $10.3M | 0.01% |
+429,026
| New | +$10.3M |
|
702
Wayfair
W
$11.3B
| $10.3M | 0.01% |
300,284
+16,218
| +6% | +$557K |
|
703
Lockheed Martin
LMT
$108B
| $10.3M | 0.01% |
21,805
-8,273
| -28% | -$3.91M |
|
704
Micron Technology
MU
$157B
| $10.2M | 0.01% |
168,921
+33,854
| +25% | +$2.04M |
|
705
US Foods
USFD
$17.5B
| $9.99M | 0.01% |
270,287
+191,623
| +244% | +$7.08M |
|
706
Liberty Global Class A
LBTYA
$3.93B
| $9.94M | 0.01% |
509,496
+12,938
| +3% | +$252K |
|
707
General Mills
GIS
$26.7B
| $9.81M | 0.01% |
114,811
-121,351
| -51% | -$10.4M |
|
708
Expensify
EXFY
$174M
| $9.73M | 0.01% |
1,194,007
+489,895
| +70% | +$3.99M |
|
709
Nasdaq
NDAQ
$54.3B
| $9.73M | 0.01% |
178,005
+80,438
| +82% | +$4.4M |
|
710
SSR Mining
SSRM
$4.46B
| $9.65M | 0.01% |
639,138
+39,042
| +7% | +$590K |
|
711
CSX Corp
CSX
$59.8B
| $9.61M | 0.01% |
321,025
-33,005
| -9% | -$988K |
|
712
Dow Inc
DOW
$16.9B
| $9.57M | 0.01% |
174,653
+85,632
| +96% | +$4.69M |
|
713
US Bancorp
USB
$76.6B
| $9.56M | 0.01% |
265,270
-832,587
| -76% | -$30M |
|
714
Hudbay
HBM
$5.33B
| $9.55M | 0.01% |
1,821,497
+1,638,521
| +895% | +$8.59M |
|
|
ZING
715
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $9.52M | 0.01% |
926,485
-263
| -0% | -$2.7K |
|
716
Cintas
CTAS
$81.2B
| $9.49M | 0.01% |
82,092
+38,304
| +87% | +$4.43M |
|
717
3M
MMM
$81.8B
| $9.47M | 0.01% |
107,809
-10,544
| -9% | -$926K |
|
718
Vor Biopharma
VOR
$228M
| $9.46M | 0.01% |
1,764,877
-95,588
| -5% | -$512K |
|
719
Otis Worldwide
OTIS
$34.4B
| $9.29M | 0.01% |
110,165
-367,608
| -77% | -$31M |
|
720
FibroGen
FGEN
$46.5M
| $9.08M | 0.01% |
19,466
+4,432
| +29% | +$2.07M |
|
721
IDEAYA Biosciences
IDYA
$2.17B
| $9.05M | 0.01% |
657,897
-26,080
| -4% | -$359K |
|
722
Paychex
PAYX
$47.9B
| $9.01M | 0.01% |
78,617
+190
| +0.2% | +$21.8K |
|
723
AST SpaceMobile
ASTS
$10.1B
| $9M | 0.01% |
1,772,152
-199
| -0% | -$1.01K |
|
724
Amprius Technologies
AMPX
$922M
| $8.92M | 0.01% |
1,024,580
-4,847
| -0.5% | -$42.2K |
|
725
Yum! Brands
YUM
$40.5B
| $8.91M | 0.01% |
67,505
-17,617
| -21% | -$2.33M |
|